ALZINOVA

Alzinova is a biopharmaceutical company dedicated to developing active and passive immunotherapies to treat Alzheimer's disease... Today, Alzheimer's disease affects almost every family, in every society. More than 30 million individuals are diagnosed with Alzheimer's. Alzinova is the pioneer in the development of a vaccine that has the potential to change that... Alzinova AB is a Swedish clinical-stage company specializing in the treatment of Alzheimer's disease - one of the major health scourges, without effective treatment options. The Company's proprietary AβCC peptide™ technology enables the development of disease-modifying therapies that with high precision could target the neurotoxic amyloid-β oligomers involved in the onset and progression of the disease.

Also known as: Alzinova AB

Primary location: Sweden